Effects of non-steroidal anti-inflammatory drugs on the prevalence of fetal structural malformations
DOI:
https://doi.org/10.33448/rsd-v9i8.5671Keywords:
Pregnancy; Anti-inflammatory drugs; Fetal development; Risk factors; Malformations.Abstract
Objective: To evaluate the use of non-steroidal anti-inflammatory drugs (NSAIDs) in the prevalence of structural congenital malformations (CM). Methods: Case-control study carried out in a public hospital that is a reference in fetal medicine. A questionnaire was applied to assess sociodemographic and obstetric factors. The evaluation of fetal morphology was performed through ultrasound evaluation. Results: Of the 282 pregnant women evaluated, 28.72% (81/282) reported use of anti-inflammatory drugs during pregnancy, 75.1% (n = 60) of the case group and 25.9% (n = 21) of the group. group control. Among the anti-inflammatory drugs, the most used were nimesulide (17.38%; n = 49), diclofenac (10.99%; n = 31) and ibuprofen (3.19%; n = 9). The use of NSAIDs in general and specific (nimesulide, diclofenac, ibuprofen) did not differ between groups. However, the highest use of ibuprofen was observed in the case group (4.46%; n = 9) vs control (0%; n = 0) with OR = 7.904, p = 0.05. The use of NSAIDs was higher in pregnant women who had fetuses with CM on the face (55.6%), abdominal wall (38.10%) and central nervous system (CNS) (30.30%). Conclusion: Although there were no differences between groups, the use of NSAIDs was considerable in patients who had a fetus with fetal malformations of the face, abdominal wall and CNS. Due to the high frequency of some malformations, especially those of the face, care should be taken with the indication and especially with the self-medication of this medication class during pregnancy.
References
Andrade, S. M., Cunha, M. A., Holanda, E. C., Coutinho, G. S. L., Verde, R. M. C. L., & Oliveira, E. H. (2020). Caracterização do perfil das intoxicações medicamentosas por automedicação no Brasil, durante o período de 2010 a 2017. Research, Society and Development, 9(7), e236973952. doi: 10.33448/rsd-v9i7.3952
Antonucci, R., Zaffanello, M., Puxeddu, E., Porcella, A., Cuzzolin, L., Pilloni, M. D, & Fanus, D. (2012). Use of Non-steroidal Anti-inflammatory Drugs in Pregnancy: Impact on the Fetus and Newborn. Curr Drug Metab, 13(4), 474–90. doi: 10.2174 / 138920012800166607
Botto, L. D., Lin, A. E., Riehle-Colarusso, T., Malik, S., & Correa, A. (2007). Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth defects Res A Clin Mol Teratol, 79(10), 714–727. doi: 10.1002 / bdra.20403
Brasil (2017). Ministério da Saúde. Relação Nacional de Medicamentos Essenciais: RENAME. 2017. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/ relacao_nacional_medicamentos_rename_2017.pdf. Acesso em 20 de abril de 2020.
Cleves, M. A., Savell, V. H., Raj, S., Zhao, W., Correa, A., Werler, M. M., Hobbs, C. A., & N. N. D. P. S. (2004). Maternal Use of Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs), and Muscular Ventricular Septal Defects. Birth defects Res A Clin Mol Teratol, 70(3), 107–113. doi: 10.1002 / bdra.20005
Damase-Michel, C., & Hurault-Delarue, C. (2014). Ibuprofen does not seem to increase global malformation risk but NSAID use in late pregnancy remains a concern. Evid Based Med, 19(2), 74. doi: 10.1136 / eb-2013-101495
Dathe, K., Fietz, A. K., Pritchard, L. W., Padberg, S., Hultzsch, S., Meixner, K., Meister, R., & Schaefer, C. (2018). No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester – Evaluation of the national Embryotox cohort. Reprod Toxicol, 79, 32–38. doi: 10.1016 / j.reprotox.2018.05.003
De Santis, M., Straface, G., Carducci, B., Cavaliere, A. F., De Santis, L., Lucchese, A., Merola, A. M., & Caruso, A. (2004). Risk of drug-induced congenital defects. Eur J Obstet Gynecol Reprod Biol, 117(1), 10–19. doi: 10.1016 / j.ejogrb.2004.04.022
Ericson, A., & Källén, B. A. J. (2001). Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol, 15(4), 371–375. doi: 10.1016/S0890-6238(01)00137-X
Fantin, C., Santos, M. L., Carvalho, L. B., Gomes, N. M., Souza, L. N., & Sousa, G. B. (2017). Estudo das anomalias cromossômicas ocorridas em uma maternidade nos anos de 2010 a 2014. Cogitare Enferm, 22 (1), 01-08. doi: 10.5380/ce.v22i1.48599
França, E. B., Lansky, S., Rego, M. A. S., Malta, D. C., França, J. S., Teixeira, R., Porto, D., Almeida, M. F., Souza, M. F. M., Szwarcwald, C. L., Mooney, M., Naghavi, M. & Vasconcelos, A. M. N. (2017). Leading causes of child mortality in Brazil, in 1990 and 2015: Estimates from the Global Burden of Disease study. Rev Bras Epidemiol, 20, 46–60. doi: /10.1590/1980-5497201700050005
Hernandez, R. K., Werler, M. M., Romitti, P., Sun, L, & Anderka, M., E. N. P. D. N. (2017). Nonsteroidal antiinflammatory drug use among women and the risk of birth defects. Am J Obs Gynecol, 25(5), 1032–57. doi: 10.1016 / j.ajog.2011.11.019
Hurtado-Gonzalez, P., Anderson, R. A., Macdonald, J., Van den Driesche, S., Kilcoyne, K., Jørgensen, A., McKinnell, C., Macpherson, S., Sharpe, R., & Mitchell, R. T. (2018). Effects of exposure to Acetaminophen and Ibuprofen on fetal germ cell development in both sexes in rodent and human using multiple experimental systems. Environ Health Perspect, 126(4), 1–17. doi: 10.1289 / EHP2307
Interrante, J. D., Ailes, E. C., Lind, J. N., Anderka, M., Feldkamp, M. L., Werler, M. M., Taylor, L. G., Trinidad, J., Gilboa, S. M., & B. C. N. B. D. P. S. (2017). Risk comparison for prenatal use of analgesics and selected birth defects, National Birth Defects Prevention Study. Physiol Behav, 176(5), 139–148. doi: 10.1016 / j.annepidem.2017.09.003
Källén, B. A. J., & Olausson, P. O. (2003). Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol, 17(3), 255–261. doi: 10.1016 / s0890-6238 (03) 00012-1
Leverrier-Penna, S., Mitchell, R. T., Becker, E., Lecante, L., Ben Maamar, M., Homer, N., Lavoué, V., Kristensen, D. M., Dejucq-Rainsford, N., Jégou, B., & Mazaud-Guittot, S. (2018). The Ibuprofen is deleterious for the development of first trimester human fetal ovary ex vivo. Hum Reprod, 33(3), 482–493. doi: 10.1093/humrep/dex383
Markovic, M., Swanson, S. A., Stricker, B. H., Jaddoe, V. W. V., Verhulst, F. C., Tiemeier H, & Marroun, H. E. (2019). Prenatal exposure to non-steroidal anti-inflammatory drugs (NSAIDs) and neurodevelopmental outcomes in children. Pharmacoepidemiol Drug Saf, 28(4), 452–459. doi: 10.1002 / pds.4625
Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., & Hernández-Díaz, S. (2011). Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am J Obstet Gynecol, 205(1), 51.e1-51.e8. doi: 10.1016/j.ajog.2011.02.029
Nezvalová-Henriksena, K., Spigsetb, O., & Nordeng, H. (2013). Effects of ibuprofen, diclofenac, naproxen, and piroxicam on the course of pregnancy and pregnancy outcome: a prospective cohort study. BJOG, 120(8), 948–959. doi: 10.1111/1471-0528.12192
Nielsen, G. L., Sørensen, H. T., Larsen, H., & Pedersen, L. (2001). Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: Population based observational study and case-control study. Br Med J, 322(7281), 266–70. doi: 10.1136 / bmj.322.7281.266
Ofori, B., Oraichi, D., Blais, L., & Rey, E. B. A. (2006). Risk of Congenital Anomalies in Pregnant Users of Non-Steroidal Anti-Inflammatory Drugs: A Nested Case-Control Study. Birth Defects Res B Dev Reprod Toxicol, 77, 228–279. doi: 10.1002 / bdrb.20085
Romani, F., Tropea, A., Scarinci, E., Federico, A., Dello Russo, C., Lisi, L., Catino, S., Lanzone, A., & Apa, R. (2014). Endocrine disrupters and human reproductive failure: the in vitro effect of phthalates on human luteal cells. Fertil Steril, 102(3), 831-837. doi: 10.1016 / j.fertnstert.2014.05.041
Rosenberg, L. E., & Rosenberg, D. D. Chapter 15 – Birth Defects. Hum Genes Genomes, 2012, 241–58.
Taye, M., Afework, M., Fantaye, W., Diro, E., & Worku, A. (2016). Magnitude of birth defects in central and northwest Ethiopia from 2010-2014: A descriptive retrospective study. PLoS One, 11(10), 1–12. doi: 10.1371/journal.pone.0161998
Van Gelder, M. M. H. J., Roeleveld, N., & Nordeng, H. (2011). Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: A prospective cohort study. PLoS One, 6(7), e22174. doi: 10.1371 / journal.pone.0022174
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Carter, A., Casey, D. C., et al. (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet, 388 (10053), 1459–544. doi: 10.1016/S0140-6736(16)31012-1
Werler, M. M., Mitchell, A. A., Hernandez-Diaz, S., & Honein, M. A. (2005). Use of over-the-counter medications during pregnancy. Am J Obstet Gynecol, 193(3), 771–7. doi: 10.1016 / j.ajog.2005.02.100
World Health Organization (WHO). Congenital anomalies. (2016). Disponível em https://www.who.int/news-room/fact-sheets/detail/congenital-anomalies. Acesso em 04 de junho de 2020.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
